tiprankstipranks
Trending News
More News >
Cytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold
PremiumRatingsCytek Biosciences Faces Revenue Challenges and Market Uncertainty, Downgraded to Hold
1M ago
Cytek Biosciences Reports Q1 2025 Financial Results
Premium
Company Announcements
Cytek Biosciences Reports Q1 2025 Financial Results
1M ago
Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
Premium
The Fly
Cytek Biosciences reports Q1 EPS (9c) vs. (5c) last year
1M ago
Strategic Resilience and Market Expansion Justify Buy Rating for Cytek Biosciences Despite Revenue Guidance Challenges
PremiumRatingsStrategic Resilience and Market Expansion Justify Buy Rating for Cytek Biosciences Despite Revenue Guidance Challenges
4M ago
Cytek Biosciences Reports Growth and Strategic Expansion
Premium
Company Announcements
Cytek Biosciences Reports Growth and Strategic Expansion
4M ago
Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
Premium
The Fly
Cytek Biosciences reports Q4 revenue $57.48M, consensus $59.38M
4M ago
Morning Movers: Wells Fargo and Citi gain following Q4 earnings
PremiumThe FlyMorning Movers: Wells Fargo and Citi gain following Q4 earnings
5M ago
Cytek Biosciences sees Q4 revenue $57M-$58M, consensus $61.49M
Premium
The Fly
Cytek Biosciences sees Q4 revenue $57M-$58M, consensus $61.49M
5M ago
Cytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
Premium
The Fly
Cytek Biosciences sees FY24 revenue $200M-$201M, consensus $204.71M
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100